Ayelet Dilion Mashiah
Our Team
About
Ayelet Dilion Mashiah is the CEO of Remedy Cell.
She has more than 20 years executive leadership in the life science Industry.
She has been the CEO of Newstem Ltd.: a pre-clinical bio-platform company for the developments of anti-cancer drugs base on Synthetic Lethality, CEO of BioMAS Ltd. ; a Phase II clinical company, Focusing on Tellurium-based compounds for pharmaceuticals. Products sold to Cosmo Pharmaceuticals (SWX: COPN) and Feramda Ltd., CEO of Do-Coop Technologies, an innovative nano-biotechnology startup and Director for TEVA’s Corporate Economic Department (NYSE:TEVA)